Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 3 - Drugs for disorders of the metabolism
Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
03/2010
03/17/2010EP2163252A1 Composition containing licorice-derived polyphenol
03/17/2010EP2163249A1 Infusion solution for peripheral intravenous administration
03/17/2010EP2162439A1 Tricyclic inhibitors of hydroxysteroid dehydrogenases
03/17/2010EP2162122A1 Compositions for prevention or treatment of anorexia-cachexia syndrome and uses thereof
03/17/2010EP1708711B1 Compositions useful especially for treatment or prevention of metabolic syndrome
03/17/2010EP1651615B1 Pyridazinyl- piperazines and their use as histamine h3 receptor ligands
03/17/2010EP1546133B1 N-substituted-2-oxodihydropyridine derivatives as npy antagonists
03/17/2010EP1315502B1 Method for treating erectile dysfunction and increasing libido in men
03/17/2010EP1303536B1 Novel fibroblast growth factor (fgf23) and methods for use
03/17/2010CN101675052A Novel 3-amido-pyrrolo[3,4-c]pyrazole-5(1h, 4h.6h) carbaldehyde derivatives
03/17/2010CN101675051A Pyrazolopyrimidine analogs and their use as mtor kinase and pi3 kinase inhibitors
03/17/2010CN101675048A 5-phenyl-6-pyridin-4-yl-1,3-dihydro-2h-imidazo[4,5-b]pyridin-2-one derivatives useful as a2b adenosine receptor antagonists
03/17/2010CN101674831A Piperidine derivatives and methods of use thereof
03/17/2010CN101674827A Benzimidazole derivatives and methods of use thereof
03/17/2010CN101674821A Composition for treating diabetes and metabolic disorders with quercetin, myrcetin and chlorogenic acid
03/17/2010CN101674819A Use of s1p receptor modulator
03/17/2010CN101671638A New strain of bifidobacterium and fermentative preparation method and application thereof
03/17/2010CN101671393A Angiopoietin-2 specific binding agents
03/17/2010CN101671373A Preparation method for iron sucrose bulk drug and injection thereof
03/17/2010CN101671346A Lindenrane-type dimerization sesquiterpenoids, preparation method and applications thereof in pharmacy
03/17/2010CN101671331A Lipoyl vildagliptin as well as preparation method and application thereof
03/17/2010CN101671329A Indolylmaleimide compound substituted with 3-amino alcohol, preparation method and application thereof
03/17/2010CN101671294A Method for continuously extracting and separating 1-deoxynojirimycin (DNJ) and flavone from folium mori
03/17/2010CN101671293A Alpha-glycosidase inhibitor compound in silkworm excrement total alkaloid and application thereof
03/17/2010CN101671260A Method for preparing O-desmethyl-venlafaxine
03/17/2010CN101671248A Long effective curcumin derivative and preparation method thereof
03/17/2010CN101670119A polynucleotide
03/17/2010CN101670111A Thioctic acid-glucan conjugate, preparation method and usage thereof
03/17/2010CN101670097A Application of cartilage oligomeric matrix protein in preparing medicine for treating vascular-calcification
03/17/2010CN101670096A Medicinal preparation containing exenatide
03/17/2010CN101670086A Chinese medicinal health wine
03/17/2010CN101670018A Method for preparing camellia saponin controlled-release tablets
03/17/2010CN101670017A Medicine combination for tonifying blood and preparation method thereof
03/17/2010CN101670010A Method for extracting flavonoid glycoside substance
03/17/2010CN101670006A Method for preparing buccal tablets for reducing blood sugar and blood lipid
03/17/2010CN101669981A Method for extracting hydroxyl naphthoquinone total pigment with supercritical carbon dioxide
03/17/2010CN101669976A Pharmaceutical composition for reducing blood lipids
03/17/2010CN101669962A Composite glycyrrhizic acid amino acid injection, and preparation method as well as applications thereof
03/17/2010CN101669954A Ferrous fumarate folic acid dispersible tablet and preparation method thereof
03/17/2010CN101669949A Compound simvastatin nicolar sustained release capsule and preparation method thereof
03/17/2010CN101669934A Suppressive activity of mango aglycone on PTP1B and application thereof
03/17/2010CN101669921A Gliclazide sustained-release capsule and preparation process thereof
03/17/2010CN101669920A Strong anti-oxidation DHA microcapsule and preparation method thereof
03/17/2010CN101669623A Beverage or oral liquid suitable for diabetes mellitus patients and preparation method thereof
03/17/2010CN100594214C Substituted oxazolobenzoisothiazole dioxide derivatives, production method and use thereof
03/17/2010CN100594034C Blood-sugar lowering A preparation for treating diabetes, its preparation method and quality-control method
03/17/2010CN100593978C Health food for pregnant woman contaning pearl shell as primary component and its preparing process
03/16/2010US7678930 Process for decreasing the amount of cholesterol in a marine oil using a volatile working fluid
03/16/2010US7678916 crystalline rosiglitazone maleate filtration
03/16/2010US7678834 Substituted 4-aminocyclohexanol compounds
03/16/2010US7678792 e.g. 3-(5-amino-2-methylphenyl)-7-chloro-1-methyl-1,6-naphthyridin-2(1H)-one; protein kinase inhibitor; antiinflammatory, anticarcinogenic, antiallergen, antidiabetic, antiischemic, hypotensive agent
03/16/2010US7678786 Benzoazepin-oxy-acetic acid derivatives as PPAR-delta agonists used for the increase of HDL-C, lower LDL-C and lower cholesterol
03/16/2010US7678777 increase a person immunity by oral administering a mixture including a dextran, promoting the cell growth and colonizing in the intestine of a subject without supplying L. casei subsp. casei at all times
03/16/2010CA2576734C Use of alk 5 inhibitors to modulate or inhibit myostatin activity leading to increased lean tissue accretion in animals
03/16/2010CA2510519C Condensed furan compounds
03/16/2010CA2415378C Oral pharmaceutical composition with controlled release and prolonged absorption
03/16/2010CA2413769C Microneedle for delivering a substance into the dermis
03/16/2010CA2396965C Piperidine- and piperazine substituted n-hydroxyformamides as inhibitors of metalloproteinases
03/16/2010CA2390590C Adenosine receptor antagonists and methods of making and using the same
03/16/2010CA2386980C Benzodiazepine derivatives for use in acute or chronic neurological disorders
03/16/2010CA2368617C Hydrogel-forming system with hydrophobic and hydrophilic components
03/16/2010CA2336846C Use of cysteine derivatives for the preparation of a medicament intended to treat pathologies which result from the formation of the heterotrimeric g protein
03/11/2010WO2010028189A2 Compounds, compositions and methods of using same for modulating uric acid levels
03/11/2010WO2010028179A1 Heterocyclic compounds as gata modulators
03/11/2010WO2010028174A1 Novel biccyclic compounds as gata modulators
03/11/2010WO2010028132A2 Novel choline cocrystal of epalrestat
03/11/2010WO2010028067A1 Pharmaceutical composition comprising eicosapentaenoic acid and nicotinic acid and methods of using same
03/11/2010WO2010027802A2 Methods for treating diabetic wounds
03/11/2010WO2010027572A2 Reducing cholesterol levels with combined use of querceting and statin
03/11/2010WO2010027498A2 Compositions and methods for inducing satiety and treating non-insulin dependent diabetes emillitus, pre-diabetic symptoms, insulin resistance and related disease states and conditions
03/11/2010WO2010027005A1 Substituted amine derivative and medicinal composition comprising same as the active ingredient
03/11/2010WO2010027002A1 Ring-fused morpholine derivative having pi3k-inhibiting activity
03/11/2010WO2010026214A1 Pyrazolopyrimidines and their use for the treatment of cns disorders
03/11/2010WO2010026154A1 A method for combating adverse effects arising from antipsychotic treatment
03/11/2010WO2010025856A1 Substituted aminoindanes and analogs thereof, and the pharmaceutical use thereof
03/11/2010WO2010025631A1 A composition of extracts from plants and the use thereof in prophylaxis or treatment of metabolism disorder of blood lipid
03/11/2010WO2010025621A1 Extracts of flavonoids-containing traditional chinese medicine, extraction method, pharmaceutical composition and application thereof
03/11/2010WO2010025553A1 Heteroaromatic compounds as inhibitors of stearoyl-coenzyme a delta-9 desaturase
03/11/2010WO2010025510A1 Libraries of peptide conjugates and methods for making them
03/11/2010WO2009149317A3 Transmucosal delivery of therapeutic agents and methods of use thereof
03/11/2010WO2009109654A3 1-benzyl-3-hydr0xymethylindaz0le derivatives and use thereof in the treatment of diseases based on the expression of mcp-1, cxcr1 and p40
03/11/2010WO2009021293A8 Agents and methods for modulating macrophage inhibitory cytokine (mic-1) activity
03/11/2010WO2009012275A9 Pyridone gpr119 g protein-coupled receptor agonists
03/11/2010WO2008094909A3 Quinazolinone and fused pyrimidinone compounds and their use in treating sodium channel-mediated diseases or conditions
03/11/2010US20100063156 Anandamide
03/11/2010US20100063151 Acylamide compounds having secretagogue or inducer activity of adiponectin
03/11/2010US20100063124 New pyrazole derivatives and diabetic medicine containing them
03/11/2010US20100063122 NOVEL 2-(2-HYDROXYPHENYL)BENZIMlDAZOLES USEFUL FOR TREATING OBESITY AND DIABETES
03/11/2010US20100063115 5-(1,3,4-oxadiazol-2-yl)-1h-indazole and 5-(1,3,4-thiadiazol-2-yl)-1h-indazole derivatives as sgk inhibitors for the treatment of diabetes
03/11/2010US20100063081 CPCR Agonists
03/11/2010US20100063079 Pyrimidyl Sulphone Amide Derivatives as Chemokine Receptor Modulators
03/11/2010US20100063065 Thiophene derivatives as ppar agonists i
03/11/2010US20100063063 Substituted Heteroaryls
03/11/2010US20100063062 Novel use of 1-[4-(5-cyanoindol-3-yl)butyl]-4-(2-carbamoyl-benzofuran-5-yl)-piperazine and its physiologically acceptable salts
03/11/2010US20100063041 Novel phenylpropionic acid derivatives as peroxisome proliferator-activated gamma receptor modulators, method of the same, and pharmaceutical composition comprising the same
03/11/2010US20100063035 Carbonic anhydrase inhibitors derivatives
03/11/2010US20100063032 Substituted pyrido[2,3-d]pyrimidine derivatives as cannabinoid-1 receptor modulators
03/11/2010US20100063025 Substituted isoquinoline and isoquinolinone derivatives as inhibitors of RHO-Kinase
03/11/2010US20100063022 Novel compounds as cannabinoid receptor ligands
03/11/2010US20100063018 orphan nuclear receptor modulators such as 23-N-Carbacinnamyloxy-3 alpha ,7 alpha -dihydroxy-5 beta -norcholanylamine, used for the treatment of liver, gastrointestinal, kidney, cardiovascular or metabolic disorders
1 ... 367 368 369 370 371 372 373 374 375 376 377 378 379 380 381 382 383 384 385 386 387 ... 1298